|
C.QNTM
|
The Company recently announced a US $20M at-the-market offering, the closing...
|
|
C.QNTM
|
In Q220, the Company continued to strengthen available cash on hand through...
|
|
C.QNTM
|
Incredible! The Company filed a pre-IND meeting request package with the U.S....
|
|
C.QNTM
|
A prospectus supplement dated October 16, 2020 describing the terms of the...
|
|
C.QNTM
|
Yes, your right! The offering has been made pursuant to an effective shelf...
|
|
C.QNTM
|
Wow! The Company has also granted A.G.P./Alliance Global Partners an option...
|
|
C.QNTM
|
Great! A.G.P./Alliance Global Partners acted as sole placement agent for the...
|
|
C.QNTM
|
The warrants have an exercise price of US$2.60 per Share, are immediately...
|
|
C.QNTM
|
Pursuant to the Settlement Agreement, the Company will pay C$5,500,000...
|
|
C.QNTM
|
You have made a good decision! The Settlement Agreement provides for a full...
|
|
C.QNTM
|
Great mindset! The Company entered into the Settlement Agreement in order to...
|
|
C.QNTM
|
Great! FSD PHARMA has entered into a definitive settlement agreement ...
|
|
C.QNTM
|
Entry into a conditional contract to sell non-core real estate asset in...
|
|
C.QNTM
|
Check this out! :) More information on the clinical trial is available...
|
|
C.QNTM
|
It great to know that the Company believes it has sufficient cash on hand to...
|
|
C.QNTM
|
FSD201 to treat 352 hospitalized COVID-19 patients in a double-blind...
|
|
C.QNTM
|
We believe FSD201 to be a safe drug with anti-inflammatory properties which...
|
|
C.QNTM
|
Filing an Investigational New Drug Application (“IND”) application with the U...
|
|
C.QNTM
|
Completion of financings for gross proceeds of $19.5 million USD through two...
|
|
C.QNTM
|
It's incredible to know that company's vision is to provide better...
|